Biosurgery Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034
Report ID: GMI3807
Download Free PDF
Authors:
Mariam Faizullabhoy ,
Biosurgery Market Size
The global biosurgery market size will grow considerably from 2025 to 2034, driven by the increasing need for sophisticated surgical procedures and the overall transition towards minimally invasive surgeries. The burden of chronic disease, along with the growing aging population, is anticipated to fuel the usage of biosurgery products in several therapeutic indications.
Based on the World Health Organization (WHO), one person in six worldwide will be 60 years and older by 2030. By 2050, the number of people 60 years and older is estimated to double, totaling 2.1 billion. The population aged 80 and above is estimated to triple between 2020 and 2050, reaching 426 million. This demographic transition is also expected to boost the number of surgical procedures, thus making biosurgery solutions stronger in terms of market outlook.
Together with demographic and epidemiological patterns, technological innovations in surgical instruments, hemostats, and regenerative materials are rewriting the rules of surgical practice. As healthcare systems around the world strive to improve surgical outcomes and minimize postoperative complications, biosurgery products are increasingly being adopted for their proven ability to enhance hemostasis, tissue sealing, and wound healing.
The biosurgery market is also being supported by the growing incidence of lifestyle disorders, including obesity, diabetes, and cardiovascular disease, that often necessitate surgical intervention. In addition, the rising incidence of orthopedic surgeries, organ transplants, and oncological surgeries is widening the use of biosurgical products. The quick growth of the healthcare infrastructure, especially in emerging economies, as well as the rising popularity of medical tourism, is providing great opportunities for growth to industry players.
With the increasing number of surgical procedures, the demand for successful biosurgery solutions to maximize clinical outcomes is on the rise as well. Additionally, increased emphasis on patient-centric care, growing healthcare awareness, and expanding disposable incomes in emerging markets are favorably positioning the market.
Biosurgery Market Trends
One of the strongest trends in the marketplace is the rising use of minimally invasive procedures (MIS) with the help of advancements in laparoscopic and robotic-assisted surgery. MIS procedures provide advantages like minimal blood loss, shorter stays in hospitals, and rapid recovery. Biosurgery products such as absorbable hemostats, sealants, and adhesives are seeing higher usage in MIS procedures.
Another key trend is the growing convergence of biotechnology and biomaterials in the creation of biosurgical products. Firms are making active investments in R&D to develop more durable, biocompatible, and effective materials that can promote tissue regeneration and minimize the immune response risk. This innovation-centric strategy is transforming the market, allowing for wider clinical application and better patient outcomes.
In addition, the increasing trend towards personalized medicine also impacts biosurgery strategies. Personalized surgical strategies and patient-specific implants are increasingly popular, which in turn require biosurgery products that are compatible with individualized treatment strategies. Furthermore, the spike in sports injuries and trauma cases is driving the demand for biosurgical products in orthopedic and emergency departments.
Biosurgery Market Analysis
The hemostatic agents market is expected to exhibit appreciable growth during the forecast period due to the growing rates of surgical procedures, trauma, and bleeding complications. Hemostats play a critical role in stopping bleeding in surgeries and are commonly used in many specialties like general surgery, orthopedics, neurosurgery, and cardiovascular surgery.
Development in formulation, ease of application, and absorption rates is improving the clinical value of hemostatic agents. Continued R&D activities are aimed at enhancing the safety and efficacy value of these products, leading to greater adoption rates. For example, companies are now formulating combination hemostats that combine mechanical and biologically active ingredients for improved performance.
The cardiovascular surgery market is anticipated to record a high CAGR during the forecast period from 2025 to 2034. This is mainly due to the rising global prevalence of cardiovascular diseases (CVDs), the leading cause of death globally. Biosurgical devices play an important part in cardiovascular operations by providing effective hemostasis, sealing of vascular grafts, and tissue regeneration. The presence of advanced surgical equipment and methods is further propelling the use of biosurgery in complicated cardiac operations.
Region-wise, the North America biosurgery market is set to continue its dominance in the forecast period, thanks to the high level of healthcare infrastructure in the region, the high level of spending on healthcare, and the strong R&D environment. The availability of major market players and early incorporation of new technologies also support the dominance of the region.
Moreover, supportive reimbursement structures and greater awareness among healthcare providers regarding the value proposition of biosurgery products are propelling product uptake in the U.S. and Canada. Additionally, the growing volume of elective procedures, combined with government efforts to enhance patient outcomes, is likely to further market growth in the region.
Asia Pacific is also becoming an attractive biosurgery market, driven by aggressive urbanization, increasing healthcare expenditure, and an expanding middle-class population with enhanced access to surgical facilities. China, India, and South Korea are experiencing booming surgical procedures, thus generating high demand for biosurgical solutions.
Biosurgery Market Share
The biosurgery industry's competitive landscape is dominated by both stalwarts and startups dealing in surgical innovation.
Major players are:
These companies are intensely investing in R&D to launch differentiated offerings and become competitive players. Strategic alliances, mergers & acquisitions, and expansion across geographies are prevalent strategies undertaken by these players to reinforce their market outreach.
Startups and mid-sized firms are adding to the competitive forces by offering niche and customized biosurgery solutions specific to particular clinical requirements. These new entrants are utilizing advanced technologies like 3D printing, nanotechnology, and bioresorbable materials to provide next-generation surgical solutions.
Biosurgery Industry News
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →